Effect of hospice care on quality indicators of end-of-life care among patients with liver cancer: a national longitudinal population-based study in Taiwan 2000–2011

Table 3 Factors associated with quality indicators of end-of-life care among patients with liver cancer

Variable	ICU admission	CPR	Anti-cancer therapy	More than one ER visit	More than one admission	Death in hospital	One or more of above indicators
Long-H vs. non-H group	0.25(0.12-0.47) p < 0.001	0.21(0.10-0.39) p < 0.001	0.84(0.48-1.40) p = 0.525	0.68(0.20-1.67) p = 0.453	1.07(0.70-1.60) p = 0.762	1.29(0.87-1.94) p = 0.204	0.99(0.62-1.60) p = 0.954
Short-H vs. non-H group	0.26(0.16-0.40) p < 0.001	0.09(0.04-0.17) p < 0.001	1.00(0.68-1.42) p = 0.986	1.97(1.25-3.02) p = 0.003	1.56(1.20-2.03) p = 0.001	2.42(1.86-3.17) p < 0.001	1.56(1.13-2.18) p = 0.008
AUC	0.724(0.703-0.746)	0.703(0.681-0.725)	0.727(0.702-0.752)	0.736 (0.696-0.776)	0.711(0.691-0.731)	0.775(0.759-0.791)	0.833(0.816-0.850)
R²	0.159	0.142	0.124	0.110	0.142	0.295	0.418

Figures are odds ratios (confidence intervals) and associated p values
Abbreviations: Non-H group, patients who did not receive hospice care; Long-H group, patients who received hospice care for longer than 1 month; Short-H group, patients who received hospice care for a period shorter than 1 month; ICU, intensive care unit; CPR, cardiopulmonary resuscitation; AUC, area under the curve. All models were adjusted according to the significant variables shown in Tables 1 and 2. The full models are in Additional file 1